Fredericks S et al. |
Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements. |
2006 |
Transplantation |
pmid:16969296
|
Peterson LB et al. |
A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimus. |
1998 |
Transplantation |
pmid:9448137
|
Rolles K et al. |
A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin. |
1999 |
Transplantation |
pmid:10551650
|
Pirsch JD |
Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group. |
1999 |
Transplantation |
pmid:10551653
|
Mañez R et al. |
Fluconazole therapy in transplant recipients receiving FK506. |
1994 |
Transplantation |
pmid:7515201
|
Hirose R et al. |
Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. |
2000 |
Transplantation |
pmid:10670644
|
Hirano Y et al. |
Morphological and functional changes of islets of Langerhans in FK506-treated rats. |
1992 |
Transplantation |
pmid:1373536
|
Naesens M et al. |
The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide. |
2007 |
Transplantation |
pmid:17700162
|
Yasunami Y et al. |
FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat. |
1990 |
Transplantation |
pmid:1691535
|
Kato T et al. |
Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year. |
2007 |
Transplantation |
pmid:17984834
|
Sindhi R et al. |
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. |
2001 |
Transplantation |
pmid:11571449
|
Jain A et al. |
Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. |
2000 |
Transplantation |
pmid:11087149
|
Koenen HJ et al. |
Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis. |
2003 |
Transplantation |
pmid:12792519
|
Egeland EJ et al. |
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation. |
2017 |
Transplantation |
pmid:28452920
|
Hricik DE et al. |
Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. |
2007 |
Transplantation |
pmid:17297401
|
Shao X et al. |
Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation. |
2012 |
Transplantation |
pmid:23128973
|
Koomans HA and Ligtenberg G |
Mechanisms and consequences of arterial hypertension after renal transplantation. |
2001 |
Transplantation |
pmid:11585243
|
Trimarchi HM et al. |
FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. |
1999 |
Transplantation |
pmid:10071024
|
Heilman RL et al. |
Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal. |
2011 |
Transplantation |
pmid:21775930
|
Kiuchi T |
CNIs: immediate benefits but storing problems for the future? |
2008 |
Transplantation |
pmid:18946338
|
Hadley S et al. |
Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. |
1995 |
Transplantation |
pmid:7535482
|
Alessiani M et al. |
Combined immunosuppressive therapy with tacrolimus and mycophenolate mofetil for small bowel transplantation in pigs. |
1996 |
Transplantation |
pmid:8830816
|
Hooper DK et al. |
Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation. |
2012 |
Transplantation |
pmid:22491658
|
Ciancio G et al. |
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up. |
2008 |
Transplantation |
pmid:18622280
|
Bolin P et al. |
Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results. |
2008 |
Transplantation |
pmid:18622283
|
Irish W et al. |
Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen. |
2003 |
Transplantation |
pmid:14688516
|
Furlan V et al. |
Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients. |
1995 |
Transplantation |
pmid:7537398
|
Akst LM et al. |
Induction of tolerance in a rat model of laryngeal transplantation. |
2003 |
Transplantation |
pmid:14688529
|
Chisholm MA et al. |
Coadministration of tacrolimus with anti-acid drugs. |
2003 |
Transplantation |
pmid:12973105
|
Koch R et al. |
Cyclosporine A-induced achalasia-like esophageal motility disorder in a liver transplant recipient: successful conversion to tacrolimus. |
2003 |
Transplantation |
pmid:12973123
|
Shapiro R et al. |
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. |
1999 |
Transplantation |
pmid:10030287
|
Paty BW et al. |
Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. |
2002 |
Transplantation |
pmid:11884930
|
Dell'Antonio G and Randhawa PS |
"Striped" pattern of medullary ray fibrosis in allograft biopsies from kidney transplant recipients maintained on tacrolimus. |
1999 |
Transplantation |
pmid:10030300
|
Kelly PA et al. |
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. |
1997 |
Transplantation |
pmid:9000686
|
Ueda M et al. |
A proposal of FK506 optimal dosing in living related liver transplantations. |
1995 |
Transplantation |
pmid:7544035
|
Stevens C et al. |
The effects of immunosuppressive agents on in vitro production of human immunoglobulins. |
1991 |
Transplantation |
pmid:1710843
|
Marin-Casino M et al. |
Significant tacrolimus and dronedarone interaction in a kidney transplant recipient. |
2014 |
Transplantation |
pmid:25243519
|
MacDonald A |
Improving tolerability of immunosuppressive regimens. |
2001 |
Transplantation |
pmid:11833142
|
Mollevà DG et al. |
Heart and liver xenotransplantation under low-dose tacrolimus: graft survival after withdrawal of immunosuppression. |
2001 |
Transplantation |
pmid:11213062
|
Pascual J et al. |
Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial. |
2010 |
Transplantation |
pmid:20335831
|
Raggi MC et al. |
Customized mycophenolate dosing based on measuring inosine-monophosphate dehydrogenase activity significantly improves patients' outcomes after renal transplantation. |
2010 |
Transplantation |
pmid:21076373
|
Sahara H et al. |
Beneficial effects of perioperative low-dose inhaled carbon monoxide on pulmonary allograft survival in MHC-inbred CLAWN miniature swine. |
2010 |
Transplantation |
pmid:21076382
|
Mathew A et al. |
Reversal of steroid-resistant rejection in renal allograft recipients using FK506. |
1995 |
Transplantation |
pmid:7482730
|
Lerut J et al. |
Anti-CD2 monoclonal antibody and tacrolimus in adult liver transplantation. |
2005 |
Transplantation |
pmid:16314784
|
Komori K et al. |
The role of graft and host accommodation in a hamster-to-rat cardiac transplantation model. |
2008 |
Transplantation |
pmid:18192920
|
Lauzurica R et al. |
Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation. |
2002 |
Transplantation |
pmid:11923710
|
Gruber SA and Doshi MD |
Conversion to sirolimus in African American renal allograft recipients undergoing early steroid withdrawal: intermediate-term risks and benefits. |
2010 |
Transplantation |
pmid:20440195
|
Vacher-Coponat H et al. |
A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. |
2012 |
Transplantation |
pmid:22228415
|
Mayer AD et al. |
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. |
1997 |
Transplantation |
pmid:9275110
|
Guitard J et al. |
Predictive factors for anemia six and twelve months after orthotopic liver transplantation. |
2006 |
Transplantation |
pmid:16770241
|